Thomson Scientific: Difference between revisions
m copy edit |
Citation bot (talk | contribs) Removed parameters. | Use this bot. Report bugs. | Suggested by Anas1712 | #UCB_webform 3766/3846 |
||
| (68 intermediate revisions by 31 users not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|Strategic business unit}} |
|||
{{Newsrelease|date=January 2008}} |
|||
'''Thomson Scientific''' was one of the six (later five) [[strategic business unit]]s of [[The Thomson Corporation]], beginning in 2007, after being separated from Thomson Scientific & Healthcare.<ref>{{cite web|url=http://www.thomson.com/corp/about/ab_home.jsp |title=About us |website=www.thomson.com |access-date=7 December 2021 |url-status=dead |archive-url=https://web.archive.org/web/20051230071516/http://www.thomson.com/corp/about/ab_home.jsp |archive-date=30 Dec 2005 |quote=The Thomson Corporation is organized into four global market groups: ...}}</ref><ref>{{cite web|url=http://www.thomson.com/content/pr/corp/corp_news/139161 |title=Thomson Announces Strategic Realignment of Operations; Company to Sell Education Businesses |website=www.thomson.com |access-date=7 December 2021 |url-status=dead |archive-url=https://web.archive.org/web/20070211063911/http://www.thomson.com/content/pr/corp/corp_news/139161 |archive-date=11 Feb 2007}}</ref> Following the merger of Thomson with [[Reuters Group]] to form [[Thomson Reuters]] in 2008, it became the "Scientific" business unit of the new company. In 2009, the unit came together with the Healthcare division of Thomson Reuters to form the Healthcare & Science division. The healthcare business was sold in 2012 to become [[Truven Health Analytics]]. The Science unit of Thomson Reuters provided information services for the academic, business, and R&D communities. It had headquarters in [[Philadelphia]], London, Singapore and Tokyo with about 2,400 staff in more than 20 countries. Its products were Aureka, Delphion, Cortellis, [[Derwent World Patents Index]] (DWPI), [[EndNote]], Horizon Global, Horizon Sourcing, IDdb, IDRAC, IP Management Services, [[ISI Web of Knowledge]], [[MicroPatent]] PatentWeb, Techstreet Industry Standards, ThomsonPharma, GeneGo, IDDB, Thomson Regulatory Solutions, and [[Web of Science]].<ref>{{cite web |
|||
{{Primarysources|date=February 2008}} |
|||
|url=http://www.thomsonreuters.com/content/footer/product_logins |title=Product Logins |website=www.thomsonreuters.com |access-date=6 December 2021 |url-status=dead |archive-url=https://web.archive.org/web/20080516030443/http://www.thomsonreuters.com/content/footer/product_logins |archive-date=16 May 2008}} The product logins page of Thomson Reuters listing their online products.</ref> |
|||
{{Nofootnotes|date=February 2008}} |
|||
In late 2011, Thomson Reuters announced a new organizational structure, with one of its divisions being Intellectual Property & Science.<ref>{{cite web |url= https://www.reuters.com/article/us-thomsonreuters-glocer-idUSTRE7B02WB20111202 |title=Smith replaces Glocer as Thomson Reuters CEO |first= |last= |date=1 December 2011 |publisher=Reuters |accessdate=13 July 2016}}</ref> This science unit of Thomson Reuters (known as IP & Science unit) was sold in 2016 to [[Onex Corporation|Onex]] and [[Baring Private Equity Asia]] for $3.5 billion. The newly independent company was named [[Clarivate Analytics]].<ref>{{Cite web |first=Bob |last=Grant |url=https://www.the-scientist.com/?articles.view/articleNo/46558/title/Web-of-Science-Sold-for-More-Than--3-Billion/ |title=Web of Science sold for more than $3 billion|website=The Scientist |date=2016-07-15 |access-date=2018-06-29}}</ref><ref name="Analytics 2016">{{cite press release |author=<!--Staff writer(s); no by-line.--> | publisher=Clarivate Analytics | title=Acquisition of the Thomson Reuters Intellectual Property and Science business by Onex and Baring Asia completed | agency=PR Newswire | date=2016-10-03 | url=https://www.prnewswire.com/news-releases/acquisition-of-the-thomson-reuters-intellectual-property-and-science-business-by-onex-and-baring-asia-completed-300337402.html | access-date=2018-06-29}}</ref> |
|||
'''Thomson Scientific''' is one of the five operating divisions of [[The Thomson Corporation]]. The Scientific division provides information-based solutions for the Academic, Business and R&D communities. |
|||
Thomson Scientific is based in [[Philadelphia]] with about 2,400 staff in more than 20 countries. |
|||
The Scientific division of Thomson provides integrated information solutions with brands like: [[Aureka]], [[Dialog (online database)|Dialog]], Delphion, [[Derwent World Patents Index]] (DWPI), [[EndNote]], Horizon Global, Horizon Sourcing, IDdb, IDRAC, IP Management Services, [[ISI Web of Knowledge]], Liquent Insight Suite, [[MicroPatent]] PatentWeb, Techstreet Industry Standards, Thomson Pharma, Thomson Regulatory Solutions, and [[Web of Science]]. |
|||
The Scientific division was combined with the Healthcare division until 2006, and was known as Thomson Scientific and Healthcare at that time. {{Fact|date=February 2008}} |
|||
==See also== |
==See also== |
||
*[[Institute for Scientific Information]] |
*[[Institute for Scientific Information]] |
||
== |
==References== |
||
{{Reflist}} |
|||
*[http://scientific.thomson.com Thomson Scientific website] |
|||
*[http://www.thomson.com Thomson Corporate website] |
|||
| ⚫ | |||
[[Category:Clarivate]] |
|||
| ⚫ | |||
{{science-stub}} |
{{science-org-stub}} |
||
{{med-company-stub}} |
{{med-company-stub}} |
||
{{US-company-stub}} |
|||
Latest revision as of 00:41, 18 June 2023
Thomson Scientific was one of the six (later five) strategic business units of The Thomson Corporation, beginning in 2007, after being separated from Thomson Scientific & Healthcare.[1][2] Following the merger of Thomson with Reuters Group to form Thomson Reuters in 2008, it became the "Scientific" business unit of the new company. In 2009, the unit came together with the Healthcare division of Thomson Reuters to form the Healthcare & Science division. The healthcare business was sold in 2012 to become Truven Health Analytics. The Science unit of Thomson Reuters provided information services for the academic, business, and R&D communities. It had headquarters in Philadelphia, London, Singapore and Tokyo with about 2,400 staff in more than 20 countries. Its products were Aureka, Delphion, Cortellis, Derwent World Patents Index (DWPI), EndNote, Horizon Global, Horizon Sourcing, IDdb, IDRAC, IP Management Services, ISI Web of Knowledge, MicroPatent PatentWeb, Techstreet Industry Standards, ThomsonPharma, GeneGo, IDDB, Thomson Regulatory Solutions, and Web of Science.[3]
In late 2011, Thomson Reuters announced a new organizational structure, with one of its divisions being Intellectual Property & Science.[4] This science unit of Thomson Reuters (known as IP & Science unit) was sold in 2016 to Onex and Baring Private Equity Asia for $3.5 billion. The newly independent company was named Clarivate Analytics.[5][6]
See also
[edit]References
[edit]- ^ "About us". www.thomson.com. Archived from the original on 30 Dec 2005. Retrieved 7 December 2021.
The Thomson Corporation is organized into four global market groups: ...
- ^ "Thomson Announces Strategic Realignment of Operations; Company to Sell Education Businesses". www.thomson.com. Archived from the original on 11 Feb 2007. Retrieved 7 December 2021.
- ^ "Product Logins". www.thomsonreuters.com. Archived from the original on 16 May 2008. Retrieved 6 December 2021. The product logins page of Thomson Reuters listing their online products.
- ^ "Smith replaces Glocer as Thomson Reuters CEO". Reuters. 1 December 2011. Retrieved 13 July 2016.
- ^ Grant, Bob (2016-07-15). "Web of Science sold for more than $3 billion". The Scientist. Retrieved 2018-06-29.
- ^ "Acquisition of the Thomson Reuters Intellectual Property and Science business by Onex and Baring Asia completed" (Press release). Clarivate Analytics. PR Newswire. 2016-10-03. Retrieved 2018-06-29.
.jpeg){kind=small} | This article about a scientific organization is a stub. You can help Wikipedia by expanding it. |
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |